Document is current

Article History

Received: 12 August 2024

Accepted: 7 September 2024

First Online: 2 November 2024

Declarations

:

: VM: No conflicts of interests. ASS: Honoraria for lectures: Amgen, Gedeon-Richter. MM: Advisor: Amgen, UCB. Speaker: Amgen, Alexion. BL: Investigator and advisor; UCB, Amgen, Samsung-Bioepis, Angitia, Entera-Bio. Speaker; Amgen, UCB, Gedeon-Richter, Astra-Zeneca.

: This article does not contain any study with human participants and animals performed by any of the authors.

: For this type of study formal consent is not required.